Mental health app for cancer survivors
Mental Health App for Cancer Survivors Study
This study is testing a mental health app designed to help people who have survived head and neck cancer manage their depression and improve their wellbeing.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 22 Years and up |
| Sex | All |
| Sponsor | University of Wisconsin, Madison Academic / other |
| Locations | 1 site (Madison, Wisconsin) |
| Trial ID | NCT06472726 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to adapt the IONA Mind app to provide mental health support specifically for patients and survivors of head and neck cancer who are experiencing depression. Participants will use the app for six weeks, engaging with personalized wellbeing plans and support based on their responses to initial assessments. The study will involve 30 participants who will be recruited from the University of Wisconsin Carbone Cancer Center and the Survey of the Health of Wisconsin. The research team will work with an advisory board of head and neck cancer survivors to ensure the app meets their unique needs.
Who should consider this trial
Good fit: Ideal candidates are adults aged 22 and older with a confirmed history of head and neck cancer and moderate to severe depression.
Not a fit: Patients with severe depression or those currently using prescription medication for depression may not benefit from this study.
Why it matters
Potential benefit: If successful, this app could significantly improve the mental health and quality of life for head and neck cancer survivors dealing with depression.
How similar studies have performed: Other studies have shown promise in using digital mental health interventions for cancer patients, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * History of HNC confirmed by histopathologic diagnosis. The signed report must be available on electronic health record (EHR) for participants who received treatment or follow-up at University of Wisconsin Carbone Cancer Center (UWCCC). Alternatively, participants must have a printed signed report if received treatment out of UWCCC * Age greater than or equal to 22 years at the time of consent * Patient Health Questionnaire-9 (PHQ-9) score ≥ 5 and ≤ 19 (moderate and severely moderate depression) * Willing to comply with all study procedures and be available for the duration of the study. Exclusion Criteria: * Unable to read and speak English. * Utilization of prescription medicine for depression. * Patient Health Questionnaire-9 (PHQ-9) score of greater than or equal to 20 (severe depression) * Patient Health Questionnaire-9 (PHQ-9) score greater than or equal to 1 on the suicidal question (question 9) * Pregnant people
Where this trial is running
Madison, Wisconsin
- University of Wisconsin Carbone Cancer Center — Madison, Wisconsin, United States (Recruiting)
Study contacts
- Principal investigator: Earlise Ward, MS, PhD, LP — University of Wisconsin, Madison
- Study coordinator: Cancer Connect
- Email: clinicaltrials@cancer.wisc.edu
- Phone: 800-622-8922
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.